Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma

NCT01573494

Conditions: Melanoma, Neoplasm Metastasis, Neoplasms, +14 more
Locations: CHU de Nice Nice, France

View Trial Details

Completed

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

NCT00623766

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Mayo Clinic Arizona Scottsdale, Arizona, United States

City Of Hope Duarte, California, United States

The Angeles Clinic & Research Institute Los Angeles, California, United States

Yale University School Of Medicine New Haven, Connecticut, United States

View all 14 locations

View Trial Details

Completed

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

NCT00025181

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

View Trial Details

Completed

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

NCT00031733

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

View Trial Details

Completed

Novel Adjuvants for Peptide-Based Melanoma Vaccines

NCT00028431

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +10 more
Locations: Universtiy of Southern California/Kenneth Norris, Jr. Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

NCT00003339

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Beckman Research Institute, City of Hope Duarte, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

NCT00003274

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

NCT00085189

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Extraocular Extension Melanoma, +31 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00334776

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

NCT00669019

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions